SLC30A2-Mediated Zinc Metabolism Modulates Gastric Cancer Progression via the Wnt/β-Catenin Signaling Pathway DOI Creative Commons
Fan Li, Xiaohong Zhang, Li Feng

et al.

Frontiers in Bioscience-Landmark, Journal Year: 2024, Volume and Issue: 29(10)

Published: Oct. 12, 2024

Background: Gastric cancer (GC) is a significant global health burden with limited treatment options. The purpose of this study was to investigate the role SLC30A2, zinc transporter, in GC development and its capacity as target for therapy. Methods: A comprehensive analysis datasets (GSE54129 stomach adenocarcinoma (STAD) from Cancer Genome Atlas (TCGA)) conducted using bioinformatics tools examine differential gene expression, focusing on SLC30A2. Functional assays, including Cell counting kit-8 (CCK-8) transwell were carried out cell lines determine impact SLC30A2 knockdown behavior. Flow cytometry utilized quantitatively observe apoptosis cycle progression. sulfate (ZnSO4) cells evaluated by detecting markers, Wnt/β-catenin signaling pathway activity, oxidative stress biomarkers, regulatory effect overexpression. Results: Our revealed upregulation samples compared normal samples, high expression linked poor prognosis. repressed proliferation, invasion, migration cells, induced apoptosis, well arrested cycle. Additionally, ZnSO4 cytotoxicity while overexpression rescued ZnSO4-induced, migration, proliferation. Moreover, had been shown bolster trigger pathway, effects which mitigated Conclusion: results implied that essential progression modulating homeostasis cellular processes. Targeting or may represent potential therapeutic approach treatment.

Language: Английский

Decoding the tumour-modulatory roles of LIMK2 DOI
Zhi Xiong Chong, Wan Yong Ho, Swee Keong Yeap

et al.

Life Sciences, Journal Year: 2024, Volume and Issue: 347, P. 122609 - 122609

Published: April 4, 2024

Language: Английский

Citations

3

Chitosan and hyaluronic acid in colorectal cancer therapy: A review on EMT regulation, metastasis, and overcoming drug resistance DOI

Mingming Han,

Xi Zhou,

Cheng Hang

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 289, P. 138800 - 138800

Published: Dec. 16, 2024

Language: Английский

Citations

2

Mir-381-3p aggravates ovariectomy-induced osteoporosis by inhibiting osteogenic differentiation through targeting KLF5/Wnt/β-catenin signaling pathway DOI Creative Commons

Yingwei Zhao,

Jingsong Liu, Yubo Zhang

et al.

Journal of Orthopaedic Surgery and Research, Journal Year: 2024, Volume and Issue: 19(1)

Published: Aug. 17, 2024

Increasing evidence shows the pivotal significance of miRNAs in pathogenesis osteoporosis. miR-381-3p has been identified as an inhibitor osteogenesis. This study explored role and mechanism postmenopausal osteoporosis (PMOP), most common type Bilateral ovariectomy (OVX) rat model was established antagomir administrated through tail vein vivo. The pathological changes rats were assessed evaluation serum bone turnover markers (BALP, PINP, CTX-1), hematoxylin eosin (H&E) staining, well expression osteoblast differentiation biomarkers. Moreover, isolated marrow mesenchymal stem cells from OVX-induced (OVX-BMMSCs) utilized to explore impact on differentiation. In addition, target gene downstream pathway further investigated both vivo vitro. elevated, whereas KLF5 suppressed OVX rats. decreased levels markers, improved trabecular separation, promoted biomarker ALP activity mineralization suppressed, biomarkers impeded after overexpression during OVX-BMMSCs. While contrasting results found inhibition miR-381-3p. targets KLF5, negatively affecting its Wnt/β-catenin pathway, Silencing restored activation induced by antagomir. aggravates PMOP inhibiting osteogenic targeting KLF5/Wnt/β-catenin pathway. appears be a promising candidate for therapeutic intervention PMOP.

Language: Английский

Citations

1

Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression DOI Creative Commons

Mohammed Saqif Ahmad,

Maria Braoudaki, Shoib Sarwar Siddiqui

et al.

PLoS ONE, Journal Year: 2024, Volume and Issue: 19(9), P. e0311212 - e0311212

Published: Sept. 30, 2024

Colorectal cancer (CRC) has become a significant global health concern and ranks among the leading causes of morbidity mortality worldwide. Due to its malignant nature, current immunotherapeutic treatments are used tackle this issue. However, not all patients respond positively treatment, thereby limiting clinical effectiveness requiring identification novel therapeutic targets optimise strategies. The putative ligand Siglec-15, Sialyl-Tn (STn), is associated with tumour progression synthesised by sialyltransferases ST6GALNAC1 ST6GALNAC2. deregulation both within literature remain limited, involvement microRNAs (miRNAs) in STn production require further elucidation. Here, we identified miRNAs involved regulation via computational approach analysis miRNA binding sites were determined. In silico tools predicted miR-21, miR-30e miR-26b regulate gene, which had shown upregulated expression cohort. Moreover, each displayed high affinity towards seed region . Additionally, enrichment outlined pathways several hallmarks, including epithelial mesenchymal transition (EMT) MYC progression. Furthermore, our findings demonstrated that profile was significantly downregulated CRC tumours, low correlated poor survival outcomes when compared patient data. comparison counterpart, there no differences ST6GALNAC2 between normal tissues, evidenced immunohistochemistry analysis. Immunohistochemistry staining highlighted higher more prevalent human tissues regard conclusion, integrated reliant on deregulated sialyltransferase CRC, regulated oncomirs. We proposed other antigen Siglec-15/Sia axis.

Language: Английский

Citations

1

SLC30A2-Mediated Zinc Metabolism Modulates Gastric Cancer Progression via the Wnt/β-Catenin Signaling Pathway DOI Creative Commons
Fan Li, Xiaohong Zhang, Li Feng

et al.

Frontiers in Bioscience-Landmark, Journal Year: 2024, Volume and Issue: 29(10)

Published: Oct. 12, 2024

Background: Gastric cancer (GC) is a significant global health burden with limited treatment options. The purpose of this study was to investigate the role SLC30A2, zinc transporter, in GC development and its capacity as target for therapy. Methods: A comprehensive analysis datasets (GSE54129 stomach adenocarcinoma (STAD) from Cancer Genome Atlas (TCGA)) conducted using bioinformatics tools examine differential gene expression, focusing on SLC30A2. Functional assays, including Cell counting kit-8 (CCK-8) transwell were carried out cell lines determine impact SLC30A2 knockdown behavior. Flow cytometry utilized quantitatively observe apoptosis cycle progression. sulfate (ZnSO4) cells evaluated by detecting markers, Wnt/β-catenin signaling pathway activity, oxidative stress biomarkers, regulatory effect overexpression. Results: Our revealed upregulation samples compared normal samples, high expression linked poor prognosis. repressed proliferation, invasion, migration cells, induced apoptosis, well arrested cycle. Additionally, ZnSO4 cytotoxicity while overexpression rescued ZnSO4-induced, migration, proliferation. Moreover, had been shown bolster trigger pathway, effects which mitigated Conclusion: results implied that essential progression modulating homeostasis cellular processes. Targeting or may represent potential therapeutic approach treatment.

Language: Английский

Citations

1